CoChat
Sign Up
Cited by 28

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

USP8 regulates liver cancer progression via the inhibition of TRAF6-mediated signal for NF-κB activation and autophagy induction by TLR4

Kim, Mi-Jeong, Choi, Bongkum, Kim, Ji Young, Min, Yoon, Kwon, Do Hee, Son, Juhee, Lee, Ji Su, Lee, Joo Sang, Chun, Eunyoung, Lee, Ki-Young·2022·Translational Oncology
DOI 10.1016/j.tranon.2021.101250PMC PMC8546492
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.tranon.2021.101250

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 70

  1. Young, 2019, The role of ubiquitin-specific peptidases in cancer progression, J. Biomed. Sci., 26, 42, 10.1186/s12929-019-0522-0 · DOI
  2. Chen, 2021, Advances in the development ubiquitin-specific peptidase (USP) inhibitors, Int. J. Mol. Sci., 22
  3. Islam, 2021, The oncogenic role of ubiquitin specific peptidase (USP8) and its signaling pathways targeting for cancer therapeutics, Arch. Biochem. Biophys., 701, 10.1016/j.abb.2021.108811 · DOI
  4. Byun, 2013, USP8 is a novel target for overcoming gefitinib resistance in lung cancer, Clin. Cancer Res., 19, 3894, 10.1158/1078-0432.CCR-12-3696 · DOI
  5. Reyes-Turcu, 2009, Polyubiquitin binding and disassembly by deubiquitinating enzymes, Chem. Rev., 109, 1495, 10.1021/cr800470j · DOI
  6. Wilkinson, 1997, Regulation of ubiquitin-dependent processes by deubiquitinating enzymes, FASEB J., 11, 1245, 10.1096/fasebj.11.14.9409543 · DOI
  7. Swatek, 2016, Ubiquitin modifications, Cell Res., 26, 399, 10.1038/cr.2016.39 · DOI
  8. Lauwers, 2009, K63-linked ubiquitin chains as a specific signal for protein sorting into the multivesicular body pathway, J. Cell Biol., 185, 493, 10.1083/jcb.200810114 · DOI
  9. Sun, 2020, The role of ubiquitination and deubiquitination in cancer metabolism, Mol. Cancer, 19, 146, 10.1186/s12943-020-01262-x · DOI
  10. Oh, 2014, USP8 modulates ubiquitination of LRIG1 for met degradation, Sci. Rep., 4, 4980, 10.1038/srep04980 · DOI
  11. Park, 2016, Roles of NF-κB in cancer and inflammatory diseases and their therapeutic approaches, Cells, 5, 15, 10.3390/cells5020015 · DOI
  12. Xia, 2014, NF-kappaB, an active player in human cancers, Cancer Immunol. Res., 2, 823, 10.1158/2326-6066.CIR-14-0112 · DOI · Paper page
  13. Bhutia, 2013, Autophagy: cancer's friend or foe?, Adv. Cancer. Res., 118, 61, 10.1016/B978-0-12-407173-5.00003-0 · DOI
  14. Zhan, 2014, Autophagy facilitates TLR4-and TLR3-triggered migration and invasion of lung cancer cells through the promotion of TRAF6 ubiquitination, Autophagy, 10, 257, 10.4161/auto.27162 · DOI
  15. Min, 2018, Inhibition of TRAF6 ubiquitin-ligase activity by PRDX1 leads to inhibition of NFKB activation and autophagy activation, Autophagy, 14, 1347, 10.1080/15548627.2018.1474995 · DOI
  16. Kim, 2020, p62 is negatively implicated in the TRAF6-BECN1 signaling axis for autophagy activation and cancer progression by Toll-Like receptor 4 (TLR4), Cells, 9, 1142, 10.3390/cells9051142 · DOI
  17. Kim, 2019, CRBN is a negative regulator of bactericidal activity and autophagy activation through inhibiting the ubiquitination of ECSIT and BECN1, Front. Immunol., 10, 2203, 10.3389/fimmu.2019.02203 · DOI
  18. Kishida, 2005, TAK1-binding protein 2 facilitates ubiquitination of TRAF6 and assembly of TRAF6 with IKK in the IL-1 signaling pathway, Genes Cells, 10, 447, 10.1111/j.1365-2443.2005.00852.x · DOI
  19. Chen, 2005, Ubiquitin signalling in the NF-kappaB pathway, Nat. Cell Biol., 7, 758, 10.1038/ncb0805-758 · DOI · Paper page
  20. Morlon, 2005, TAB2, TRAF6 and TAK1 are involved in NF-kappaB activation induced by the TNF-receptor, Edar and its adaptator Edaradd, Hum. Mol. Genet., 14, 3751, 10.1093/hmg/ddi405 · DOI
  21. Moon, 2015, Phosphoinositide-dependent kinase-1 inhibits TRAF6 ubiquitination by interrupting the formation of TAK1-TAB2 complex in TLR4 signaling, Cell. Signal., 27, 2524, 10.1016/j.cellsig.2015.09.018 · DOI
  22. Shi, 2010, TRAF6 and A20 regulate lysine 63-linked ubiquitination of Beclin-1 to control TLR4-induced autophagy, Sci. Signal, 3, ra42, 10.1126/scisignal.2000751 · DOI
  23. Shi, 2010, Traf6 and A20 differentially regulate TLR4-induced autophagy by affecting the ubiquitination of Beclin 1, Autophagy, 6, 986, 10.4161/auto.6.7.13288 · DOI
  24. Xu, 2016, USP14 regulates autophagy by suppressing K63 ubiquitination of Beclin 1, Genes Dev., 30, 1718, 10.1101/gad.285122.116 · DOI
  25. Min, 2017, Ubiquitin-specific protease 14 negatively regulates toll-like receptor 4-mediated signaling and autophagy induction by inhibiting ubiquitination of TAK1-binding protein 2 and beclin 1, Front. Immunol., 8, 1827, 10.3389/fimmu.2017.01827 · DOI
  26. Kaur, 2019, Classification of early and late stage liver hepatocellular carcinoma patients from their genomics and epigenomics profiles, PLoS ONE, 14, 10.1371/journal.pone.0221476 · DOI
  27. Elsharkawy, 2007, Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis, Hepatology, 46, 590, 10.1002/hep.21802 · DOI
  28. Dai, 2015, Golgi phosphoprotein 3 (GOLPH3) promotes hepatocellular carcinoma cell aggressiveness by activating the NF-kappaB pathway, J. Pathol., 235, 490, 10.1002/path.4479 · DOI
  29. Toshima, 2014, Autophagy enhances hepatocellular carcinoma progression by activation of mitochondrial beta-oxidation, J. Gastroenterol., 49, 907, 10.1007/s00535-013-0835-9 · DOI
  30. Meng, 2020, Role of the autophagy-related marker LC3 expression in hepatocellular carcinoma: a meta-analysis, J. Cancer Res. Clin. Oncol., 146, 1103, 10.1007/s00432-020-03174-1 · DOI
  31. Yancopoulos, 2000, Vascular-specific growth factors and blood vessel formation, Nature, 407, 242, 10.1038/35025215 · DOI · Paper page
  32. Moon, 2009, Sulforaphane suppresses TNF-α-mediated activation of NF-κB and induces apoptosis through activation of reactive oxygen species-dependent caspase-3, Cancer Lett., 274, 132, 10.1016/j.canlet.2008.09.013 · DOI
  33. Shimizu, 2012, Indoxyl sulfate upregulates renal expression of MCP-1 via production of ROS and activation of NF-κB, p53, ERK, and JNK in proximal tubular cells, Life Sci., 90, 525, 10.1016/j.lfs.2012.01.013 · DOI
  34. Li, 2020, Autophagy and autophagy-related proteins in cancer, Mol. Cancer, 19, 1, 10.1186/s12943-019-1085-0 · DOI
  35. Chao, 2020, Autophagy and liver cancer, Clin. Mol. Hepatol., 26, 606, 10.3350/cmh.2020.0169 · DOI
  36. Campbell, 2018, USP8 deubiquitinates SHANK3 to control synapse density and SHANK3 activity-dependent protein levels, J. Neurosci., 38, 5289, 10.1523/JNEUROSCI.3305-17.2018 · DOI
  37. Leem, 2020, 4-1BB co-stimulation further enhances anti-PD-1-mediated reinvigoration of exhausted CD39+ CD8 T cells from primary and metastatic sites of epithelial ovarian cancers, J. Immunother. Cancer, 8, 10.1136/jitc-2020-001650 · DOI
  38. Kim, 2015, HISAT: a fast spliced aligner with low memory requirements, Nat. Methods, 12, 357, 10.1038/nmeth.3317 · DOI · Paper page
  39. Pertea, 2015, StringTie enables improved reconstruction of a transcriptome from RNA-seq reads, Nat. Biotechnol., 33, 290, 10.1038/nbt.3122 · DOI
  40. Pertea, 2016, Transcript-level expression analysis of RNA-seq experiments with HISAT, StringTie and Ballgown, Nat. Protoc., 11, 1650, 10.1038/nprot.2016.095 · DOI
  41. Robinson, 2010, edgeR: a Bioconductor package for differential expression analysis of digital gene expression data, Bioinformatics, 26, 139, 10.1093/bioinformatics/btp616 · DOI · Paper page
  42. Lowe, 2006, Ubiquitination and de-ubiquitination: role in regulation of signaling by Toll-like receptors, J. Endotoxin Res., 12, 337
  43. Walsh, 2008, TRAF6 autoubiquitination-independent activation of the NFκB and MAPK pathways in response to IL-1 and RANKL, PLoS ONE, 3, e4064, 10.1371/journal.pone.0004064 · DOI
  44. Ajibade, 2013, Cell type-specific function of TAK1 in innate immune signaling, Trends Immunol., 34, 307, 10.1016/j.it.2013.03.007 · DOI
  45. Peng, 2017, Ubiquitylation of p62/sequestosome1 activates its autophagy receptor function and controls selective autophagy upon ubiquitin stress, Cell Res., 27, 657, 10.1038/cr.2017.40 · DOI
  46. Yang, 2018, SQSTM1/p62 (sequestosome 1) senses cellular ubiquitin stress through E2-mediated ubiquitination, Autophagy, 14, 1072
  47. Peng, 2020, The ubiquitin-specific protease USP8 directly deubiquitinates SQSTM1/p62 to suppress its autophagic activity, Autophagy, 16, 698, 10.1080/15548627.2019.1635381 · DOI · Paper page
  48. Luo, 2016, PSMD10/gankyrin induces autophagy to promote tumor progression through cytoplasmic interaction with ATG7 and nuclear transactivation of ATG7 expression, Autophagy, 12, 1355, 10.1080/15548627.2015.1034405 · DOI
  49. Liu, 2018, Cytoplasmic liver kinase B1 promotes the growth of human lung adenocarcinoma by enhancing autophagy, Cancer Sci., 109, 3055, 10.1111/cas.13746 · DOI
  50. Ding, 2011, Autophagy activation in hepatocellular carcinoma contributes to the tolerance of oxaliplatin via reactive oxygen species modulation, Clin. Cancer Res., 17, 6229, 10.1158/1078-0432.CCR-11-0816 · DOI
  51. Shi, 2011, Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis, Autophagy, 7, 1159, 10.4161/auto.7.10.16818 · DOI
  52. Yang, 2015, Emerging role of Toll-like receptor 4 in hepatocellular carcinoma, J. Hepatocell. Carcinoma, 2, 11
  53. Okuda, 2012, Hyaluronan synthase HAS2 promotes tumor progression in bone by stimulating the interaction of breast cancer stem–like cells with macrophages and stromal cells, Cancer Res., 72, 537, 10.1158/0008-5472.CAN-11-1678 · DOI
  54. Yang, 2017, CCL28 promotes breast cancer growth and metastasis through MAPK-mediated cellular anti-apoptosis and pro-metastasis, Oncol. Rep., 38, 1393, 10.3892/or.2017.5798 · DOI
  55. Ye, 2017, JCAD promotes progression of nonalcoholic steatohepatitis to liver cancer by inhibiting LATS2 kinase activity, Cancer Res., 77, 5287, 10.1158/0008-5472.CAN-17-0229 · DOI
  56. Ni, 2015, Serum amyloid A is a novel prognostic biomarker in hepatocellular carcinoma, Asian Pac. J. Cancer Prev., 15, 10713, 10.7314/APJCP.2014.15.24.10713 · DOI
  57. Li, 2011, Activation of PPARγ in myeloid cells promotes lung cancer progression and metastasis, PLoS ONE, 6, e28133, 10.1371/journal.pone.0028133 · DOI
  58. Ghanem, 2014, Insights on the CXCL12-CXCR4 axis in hepatocellular carcinoma carcinogenesis, Am. J. Transl. Res., 6, 340
  59. Lian, 2016, PRL-3 promotes cell adhesion by interacting with JAM2 in colon cancer, Oncol. Lett., 12, 1661, 10.3892/ol.2016.4836 · DOI
  60. Chen, 2013, Expression of FOXJ1 in hepatocellular carcinoma: correlation with patients' prognosis and tumor cell proliferation, Mol. Carcinog., 52, 647, 10.1002/mc.21904 · DOI
  61. Famili, 2015, Discrete roles of canonical and non-canonical Wnt signaling in hematopoiesis and lymphopoiesis, Cell Death Dis., 6, e1981, 10.1038/cddis.2015.326 · DOI
  62. Yang, 2017, FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer, Mol. Cancer, 16, 1, 10.1186/s12943-017-0700-1 · DOI
  63. Lv, 2020, The multiple roles of deubiquitinases in liver cancer, Am. J. Cancer Res., 10, 1647
  64. Dawson, 2008, Hepatocellular carcinoma and the ubiquitin–proteasome system, Biochim. Biophys. Acta BBA Mol. Basis Dis., 1782, 775, 10.1016/j.bbadis.2008.08.003 · DOI
  65. Ni, 2017, Expression of OTUB1 in hepatocellular carcinoma and its effects on HCC cell migration and invasion, Acta Biochim. Biophys. Sin., 49, 680, 10.1093/abbs/gmx056 · DOI
  66. Zhang, 2018, Ubiquitin-specific protease 11 serves as a marker of poor prognosis and promotes metastasis in hepatocellular carcinoma, Lab. Investig., 98, 883, 10.1038/s41374-018-0050-7 · DOI
  67. Wang, 2015, Decreased Cezanne expression is associated with the progression and poor prognosis in hepatocellular carcinoma, J. Transl. Med., 13, 1, 10.1186/s12967-015-0396-1 · DOI
  68. Tang, 2015, Expression of USP22 and Survivin is an indicator of malignant behavior in hepatocellular carcinoma, Int. J. Oncol., 47, 2208, 10.3892/ijo.2015.3214 · DOI
  69. Zhao, 2020, USP8 protects against lipopolysaccharide-induced cognitive and motor deficits by modulating microglia phenotypes through TLR4/MyD88/NF-κB signaling pathway in mice, Brain Behav. Immun., 88, 582, 10.1016/j.bbi.2020.04.052 · DOI
  70. Zhang, 2018, Effect of deubiquitinase USP8 on hypoxia/reoxygenation‑induced inflammation by deubiquitination of TAK1 in renal tubular epithelial cells, Int. J. Mol. Med., 42, 3467

Cited by

Sorted by citations

Metadata

Authors
Kim, M.-J., Choi, B., Kim, J. Y., Min, Y., Kwon, D. H., Son, J., Lee, J. S., Lee, J. S., Chun, E., & Lee, K.-Y.
Venue
Translational Oncology
Publisher
Elsevier BV
Published
2022-01
Volume
15
Issue
1
Pages
101250
ISSN
1936-5233
DOI
10.1016/j.tranon.2021.101250
PMC
PMC8546492
Cited by
28
References
2
Language
en
Licence
Funders
National Research Foundation of Korea (NRF-2021R1A2C1094478, NRF-2021R1F1A1049324)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review